<DOC>
	<DOCNO>NCT00005839</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness oxaliplatin combine capecitabine treat patient metastatic recurrent solid tumor .</brief_summary>
	<brief_title>Oxaliplatin Plus Capecitabine Treating Patients With Metastatic Recurrent Solid Tumor</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose capecitabine administer combination oxaliplatin patient metastatic recurrent solid tumor . II . Determine toxicities treatment regimen patient population . OUTLINE : This dose escalation study capecitabine . Patients receive oxaliplatin IV 2 hour day 1 oral capecitabine twice daily day 1-14 . Treatment repeat every 2 week absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos capecitabine maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 6 patient experience dose limit toxicity . Patients follow disease progression survival . PROJECTED ACCRUAL : A total 12-15 patient accrue study .</detailed_description>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm metastatic recurrent solid tumor fail standard therapy standard therapy exist No known brain metastasis carcinomatosis meningitis PATIENT CHARACTERISTICS : Age : 18 Performance status : SWOG 02 Karnofsky 60100 % Life expectancy : At least 12 week Hematopoietic : WBC least 3,000/mm3 Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2 time normal AST great 2.5 time normal Renal : Creatinine normal OR Creatinine clearance great 60 mL/min Calcium great 12 mg/dL Cardiovascular : No symptomatic congestive heart failure No unstable angina pectoris No cardiac arrhythmia Other : No evidence neuropathy No history allergy platinum compound antiemetic would preclude study No uncontrolled illness ( e.g. , ongoing active infection ) No medical , social , psychological factor would preclude study Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy recover Chemotherapy : At least 4 week since prior chemotherapy ( 6 week mitomycin nitrosoureas ) recover Prior fluorouracil cisplatin allow Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy recover Surgery : Recovered prior surgery Other : At least 30 day since prior investigational drug No concurrent antiretroviral therapy ( HAART )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>